Elgilda Musi

1.0k total citations
25 papers, 852 citations indexed

About

Elgilda Musi is a scholar working on Molecular Biology, Ophthalmology and Oncology. According to data from OpenAlex, Elgilda Musi has authored 25 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Ophthalmology and 8 papers in Oncology. Recurrent topics in Elgilda Musi's work include Ocular Oncology and Treatments (10 papers), Sarcoma Diagnosis and Treatment (4 papers) and Immunotherapy and Immune Responses (4 papers). Elgilda Musi is often cited by papers focused on Ocular Oncology and Treatments (10 papers), Sarcoma Diagnosis and Treatment (4 papers) and Immunotherapy and Immune Responses (4 papers). Elgilda Musi collaborates with scholars based in United States, Canada and France. Elgilda Musi's co-authors include Gary K. Schwartz, Grazia Ambrosini, Elisa de Stanchina, Alan L. Ho, Jayasree S. Nair, Parag P. Patwardhan, Richard D. Carvajal, Ashley Sawle, Christiane Deregnaucourt and Alberto Martínez and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Elgilda Musi

25 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elgilda Musi United States 13 450 304 182 148 117 25 852
Miriam Redrado Spain 20 544 1.2× 518 1.7× 118 0.6× 177 1.2× 233 2.0× 39 1.1k
Alejandro Parrales United States 13 698 1.6× 463 1.5× 36 0.2× 110 0.7× 173 1.5× 19 1.1k
Katja Parapatics Austria 14 762 1.7× 195 0.6× 52 0.3× 49 0.3× 126 1.1× 18 962
Caterina Ieranò Italy 20 546 1.2× 917 3.0× 31 0.2× 119 0.8× 462 3.9× 34 1.4k
G. Mangold Germany 17 661 1.5× 437 1.4× 21 0.1× 132 0.9× 49 0.4× 46 1.2k
Claire Fabre France 19 752 1.7× 444 1.5× 19 0.1× 105 0.7× 234 2.0× 43 1.3k
Kristy J. Gotink Netherlands 7 609 1.4× 294 1.0× 12 0.1× 252 1.7× 42 0.4× 8 975
Annemarie Larkin Ireland 18 477 1.1× 318 1.0× 24 0.1× 60 0.4× 72 0.6× 32 770
A. Kathleen McClendon United States 17 904 2.0× 937 3.1× 31 0.2× 607 4.1× 29 0.2× 20 1.6k
Kevin P. Callahan United States 11 1.0k 2.2× 186 0.6× 50 0.3× 56 0.4× 127 1.1× 29 1.5k

Countries citing papers authored by Elgilda Musi

Since Specialization
Citations

This map shows the geographic impact of Elgilda Musi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elgilda Musi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elgilda Musi more than expected).

Fields of papers citing papers by Elgilda Musi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elgilda Musi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elgilda Musi. The network helps show where Elgilda Musi may publish in the future.

Co-authorship network of co-authors of Elgilda Musi

This figure shows the co-authorship network connecting the top 25 collaborators of Elgilda Musi. A scholar is included among the top collaborators of Elgilda Musi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elgilda Musi. Elgilda Musi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ambrosini, Grazia, Christopher A. Natale, Elgilda Musi, Tina Garyantes, & Gary K. Schwartz. (2023). The GPER Agonist LNS8801 Induces Mitotic Arrest and Apoptosis in Uveal Melanoma Cells. Cancer Research Communications. 3(4). 540–547. 10 indexed citations
2.
Totiger, Tulasigeri M., Elgilda Musi, Stanley Chun-Wei Lee, et al.. (2023). Protein biomarkers for response to XPO1 inhibition in haematologic malignancies. Journal of Cellular and Molecular Medicine. 27(4). 587–590. 9 indexed citations
3.
Musi, Elgilda, Tahir Sheikh, Matthew Ingham, Sminu Bose, & Gary K. Schwartz. (2023). Abstract 6174: ATX-101, a peptide drug targeting PCNA, enhances the effect of gemcitabine in liposarcoma and leiomyosarcoma. Cancer Research. 83(7_Supplement). 6174–6174. 1 indexed citations
4.
Bao, Riyue, Oliver Surriga, Daniel J. Olson, et al.. (2020). Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target. Melanoma Research. 31(1). 27–37. 11 indexed citations
5.
Oza, Jay, et al.. (2020). Homologous recombination repair deficiency as a therapeutic target in sarcoma. Seminars in Oncology. 47(6). 380–389. 29 indexed citations
6.
Ambrosini, Grazia, Catherine Do, Benjamin Tycko, et al.. (2019). Inhibition of NF-κB–Dependent Signaling Enhances Sensitivity and Overcomes Resistance to BET Inhibition in Uveal Melanoma. Cancer Research. 79(9). 2415–2425. 34 indexed citations
7.
Musi, Elgilda, Gary K. Schwartz, Jae Hyuk Yoo, et al.. (2019). Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo. Oncotarget. 10(43). 4424–4436. 7 indexed citations
8.
Patwardhan, Parag P., Elgilda Musi, & Gary K. Schwartz. (2018). Preclinical Evaluation of Nintedanib, a Triple Angiokinase Inhibitor, in Soft-tissue Sarcoma: Potential Therapeutic Implication for Synovial Sarcoma. Molecular Cancer Therapeutics. 17(11). 2329–2340. 12 indexed citations
9.
Musi, Elgilda, Grazia Ambrosini, Joanne M. Munck, & Gary K. Schwartz. (2018). Abstract 5784: A novel ERK inhibitor in the treatment of uveal melanoma. Cancer Research. 78(13_Supplement). 5784–5784. 1 indexed citations
10.
Ambrosini, Grazia, Ashley Sawle, Elgilda Musi, & Gary K. Schwartz. (2015). BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells. Oncotarget. 6(32). 33397–33409. 49 indexed citations
11.
Musi, Elgilda, Grazia Ambrosini, Elisa de Stanchina, & Gary K. Schwartz. (2014). The Phosphoinositide 3-Kinase α Selective Inhibitor BYL719 Enhances the Effect of the Protein Kinase C Inhibitor AEB071 in GNAQ/GNA11-Mutant Uveal Melanoma Cells. Molecular Cancer Therapeutics. 13(5). 1044–1053. 52 indexed citations
12.
Ambrosini, Grazia, Elgilda Musi, Alan L. Ho, Elisa de Stanchina, & Gary K. Schwartz. (2013). Inhibition of Mutant GNAQ Signaling in Uveal Melanoma Induces AMPK-Dependent Autophagic Cell Death. Molecular Cancer Therapeutics. 12(5). 768–776. 85 indexed citations
13.
Musi, Elgilda, Grazia Ambrosini, & Gary K. Schwartz. (2013). Abstract 2073: The parp inhibitor olaparib (AZD2281) greatly enances the effect of temozolomide in soft tissue sarcoma cell lines.. Cancer Research. 73(8_Supplement). 2073–2073. 2 indexed citations
14.
Luke, Jason J., David R. D’Adamo, Mark A. Dickson, et al.. (2012). The Cyclin-Dependent Kinase Inhibitor Flavopiridol Potentiates Doxorubicin Efficacy in Advanced Sarcomas: Preclinical Investigations and Results of a Phase I Dose-Escalation Clinical Trial. Clinical Cancer Research. 18(9). 2638–2647. 82 indexed citations
15.
Ho, Alan L., Elgilda Musi, Grazia Ambrosini, et al.. (2012). Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype. PLoS ONE. 7(7). e40439–e40439. 59 indexed citations
16.
Ambrosini, Grazia, Elgilda Musi, Jean‐Philip Truman, et al.. (2009). Safingol (l-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway. Autophagy. 5(2). 184–193. 93 indexed citations
17.
Musi, Elgilda, Naziba Islam, & Joan H.F. Drosopoulos. (2007). Constraints imposed by transmembrane domains affect enzymatic activity of membrane-associated human CD39/NTPDase1 mutants. Archives of Biochemistry and Biophysics. 461(1). 30–39. 12 indexed citations
18.
Lazzarino, Deborah A., et al.. (2001). IL-8 AND MCP-1 SECRETION IS ENHANCED BY THE PEPTIDE-NUCLEIC ACID IMMUNOMODULATOR, PRODUCT R, IN U937 CELLS AND PRIMARY HUMAN MONOCYTES. Cytokine. 14(4). 234–239. 15 indexed citations
19.
Lazzarino, Deborah A., et al.. (2000). CXCR4 and CCR5 expression by H9 T-cells is downregulated by a peptide-nucleic acid immunomodulator. Immunology Letters. 74(3). 189–195. 11 indexed citations
20.
Musi, Elgilda, et al.. (1990). Role of extracellular calcium on heart muscle energetics: effects of verapamil. American Journal of Physiology-Heart and Circulatory Physiology. 258(1). H64–H72. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miriam Redrado Breakdown of academic impact, for papers by Alejandro Parrales Breakdown of academic impact, for papers by Katja Parapatics Breakdown of academic impact, for papers by Caterina Ieranò Breakdown of academic impact, for papers by G. Mangold Breakdown of academic impact, for papers by Claire Fabre Breakdown of academic impact, for papers by Kristy J. Gotink Breakdown of academic impact, for papers by Annemarie Larkin Breakdown of academic impact, for papers by A. Kathleen McClendon Breakdown of academic impact, for papers by Kevin P. Callahan
Rankless by CCL
2026